Many older Americans on Medicare are shocked to find that the newly approved Covid shots aren't covered, leading to hefty out-of-pocket expenses. Health officials claim coverage should be available, but patients report otherwise. What's going on?
As Social Security and Medicare trust funds face insolvency by 2034, experts warn that bond market pressures could force Congress into painful fiscal reforms. Will lawmakers finally tackle the 'third rail' of politics?
In a surprising move, Warren Buffett's Berkshire Hathaway invests $1.6 billion in UnitedHealth Group, a stock down 40% this year. Can this gamble pay off amid turmoil?
UnitedHealth Group's stock continues to decline as the insurer battles rising medical costs and a challenging earnings outlook. Following the abrupt CEO change, the company anticipates no earnings growth until 2026.
UnitedHealth Group's upcoming earnings report has sparked intense social media buzz as its stock faces a dramatic decline. Analysts weigh in on the potential for recovery or a value trap amid industry challenges.
A recent report reveals that the U.S. Social Security and Medicare programs will run short of funds by 2033, three years earlier than expected. As expenditures rise, lawmakers must act quickly to address looming financial challenges.
A new report reveals that the Social Security trust fund may be depleted in eight years, risking a 23% cut in benefits for over 60 million Americans. Experts urge Congress to act now to prevent drastic reductions.
As the national debt surpasses $36.2 trillion, looming Medicare cuts could shock millions. Experts warn that these budget reductions may have dire consequences for healthcare access, especially for the elderly and disabled.
After a steep 18% drop, UnitedHealth Group's shares saw a modest rebound as analysts maintain positive ratings despite the company withdrawing its guidance and the CEO's resignation. Will the stock recover?
In a surprising move, UnitedHealth Group CEO Andrew Witty has stepped down, citing personal reasons. Board chairman Stephen Hemsley takes over as the company navigates significant industry challenges.